BioMAP® T Cell Autoimmune Panel

BioMAP® T Cell Autoimmune Panel
Version:
20878

Year:
2018

For autoimmune indications, the challenge is to design treatments that selectively reduce unwanted autoimmunityrelated injury without disrupting healthy immune function. Current models for studying candidate drugs, especially chemically-induced animal testing, rarely fully predict the effects a candidate drug will have in humans. The BioMAP T Cell Autoimmune Panel was created to more fully predict efficacy across a range of immune-related diseases in a format that is faster, higher throughput, and more clinically relevant than current methods.